{"title":"一种新的小分子仿制药开发和组合管理策略:Watergile ANDA","authors":"Sandra Tomassini, A. Pazhayattil, Marzena Ingram","doi":"10.1177/1741134320918339","DOIUrl":null,"url":null,"abstract":"Ninety per cent of US prescriptions volumes are generic drug products. Solid oral products constitute more than 75% of the generic drugs. The generic product development and commercialization incor...","PeriodicalId":91117,"journal":{"name":"Journal of generic medicines","volume":"64 1","pages":"174113432091833"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Novel Development and Portfolio Management Strategy for Generic Small Molecule Drug Products: Watergile ANDA\",\"authors\":\"Sandra Tomassini, A. Pazhayattil, Marzena Ingram\",\"doi\":\"10.1177/1741134320918339\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ninety per cent of US prescriptions volumes are generic drug products. Solid oral products constitute more than 75% of the generic drugs. The generic product development and commercialization incor...\",\"PeriodicalId\":91117,\"journal\":{\"name\":\"Journal of generic medicines\",\"volume\":\"64 1\",\"pages\":\"174113432091833\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of generic medicines\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1741134320918339\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of generic medicines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1741134320918339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Novel Development and Portfolio Management Strategy for Generic Small Molecule Drug Products: Watergile ANDA
Ninety per cent of US prescriptions volumes are generic drug products. Solid oral products constitute more than 75% of the generic drugs. The generic product development and commercialization incor...